GPCRs in Addiction
-
Chair(s):
Andrew Lawrence,
Division Head, Florey Institute of Neuroscience & Mental Health, Parkville, AustraliaChris Langmead ,
Monash Institute of Pharmaceutical Sciences, Parkville, Australia -
Session description:
Development of novel GPCR therapeutics for substance use disorders
Professor Paul Kenny
Director, Drug Discovery Institute, Icahn School of Medicine at Mt Sinai, NY, The United States of AmericaThe role of muscarinic receptors in alcohol seeking
Dr Leigh Walker
Florey Institute of Neuroscience & Mental Health, University of Melbourne, Parkville, AustraliaOral communication speaker - to be confirmed in 2022.
Targeting GABA-B receptors for treatment of alcohol addiction
Professor Markus Heilig
Linköping University, Linköping , SwedenMetabotropic glutamate receptor modulation of striatal circuits involved in reinforcement learning and addiction
Dr Kari Johnson
Uniformed Services University of the Health Sciences, Bethesda, The United States of AmericaSponsored by:
Speakers
-
Dr Kari JohnsonUniformed Services University of the Health Sciences, Bethesda, The United States of America
-
Dr Leigh WalkerFlorey Institute of Neuroscience & Mental Health, University of Melbourne, Parkville, Australia
-
Professor Markus HeiligLinköping University, Linköping , Sweden
-
Professor Paul KennyDirector, Drug Discovery Institute, Icahn School of Medicine at Mt Sinai, NY, The United States of America